Catalyst Wire Dossier Catalyst Wire Dossier

PROMUS Element Everolimus-eluting Stent

everolimus-eluting stent · Boston Scientific
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PROMUS Element Everolimus-eluting Stent, covering 2012-08-22 to 2014-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent [Phase 4]

See pricing